Items where authors include "Ross, R.J."

Article

Date, K.L. orcid.org/0009-0006-4476-3802, Baster, K., Caunt, S.L. et al. (7 more authors) (2024) Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol. BMJ Open, 14 (12). e094830. ISSN 2044-6055

Whitaker, M.J., Debono, M. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2024) Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia. Clinical Endocrinology, 101 (4). pp. 311-317. ISSN 0300-0664

Rees, A.D., Merke, D.P., Arlt, W. et al. (12 more authors) (2024) Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia. Endocrine Connections, 13 (8). e240150. ISSN 2049-3614

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Arshad, M.F. orcid.org/0000-0001-9932-0941, Pofi, R. orcid.org/0000-0001-7808-5735 et al. (7 more authors) (2023) Multivariable model to predict an ACTH stimulation test to diagnose adrenal insufficiency using previous test results. Journal of the Endocrine Society, 7 (12). bvad127. ISSN 2472-1972

Righi, B. orcid.org/0000-0003-4084-1077, Ali, S.R., Bryce, J. et al. (19 more authors) (2023) Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia. Endocrine, 80 (3). pp. 630-638. ISSN 1355-008X

Stachanow, V. orcid.org/0000-0003-0018-4623, Neumann, U., Blankenstein, O. orcid.org/0000-0003-1803-5589 et al. (9 more authors) (2023) Model-Informed target morning 17α-hydroxyprogesterone concentrations in dried blood spots for pediatric congenital adrenal hyperplasia patients. Pharmaceuticals, 16 (3). 464. ISSN 1424-8247

Debono, M. orcid.org/0000-0002-1059-9702, Elder, C.J. orcid.org/0000-0003-2390-5593, Lewis, J. et al. (8 more authors) (2023) Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evidence, 2 (2). ISSN 2766-5526

Whitaker, M.J., Huatan, H. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2023) Chronotherapy based on modified-release hydrocortisone to restore the physiological cortisol diurnal rhythm. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 13 (1). pp. 1-8. ISSN 2190-393X

Tonge, J.J., Keevil, B.G., Craig, J.N. et al. (3 more authors) (2022) Main salivary steroid collection in children under conditions replicating home sampling. Journal of Clinical Endocrinology and Metabolism, 107 (11). dgac419. pp. 3128-3136. ISSN 0021-972X

Ramezanipour, N., Esfahani, S.H.Z., Eastell, R. orcid.org/0000-0002-0323-3366 et al. (4 more authors) (2022) Development of a hypoparathyroid male rodent model for testing delayed-clearance PTH molecules. Endocrinology, 163 (2). bqab239. ISSN 0013-7227

Prete, A., Auchus, R.J. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2022) Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia. European Journal of Endocrinology, 186 (1). R1-R14. ISSN 0804-4643

Newell-Price, J., Huatan, H., Quirke, J. et al. (7 more authors) (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185 (5). pp. 607-615. ISSN 0804-4643

Bonner, J.J., Burt, H., Johnson, T.N. et al. (3 more authors) (2021) Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency. European Journal of Pharmaceutical Sciences, 165. 105913. ISSN 0928-0987

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X

Bacila, I., Freeman, N., Daniel, E. et al. (42 more authors) (2021) International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia - data from the I-CAH registry. European Journal of Endocrinology, 184 (4). pp. 553-563. ISSN 0804-4643

Walsh, J.S. orcid.org/0000-0002-7122-2650, Marshall, H., Smith, I.L. et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors : a 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277

Melin, J., Hartung, N., Parra-Guillen, Z.P. et al. (3 more authors) (2019) The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosing. Clinical Endocrinology, 91 (1). pp. 33-40. ISSN 0300-0664

Daniel, E. orcid.org/0000-0003-4699-420X, Digweed, D., Quirke, J. et al. (3 more authors) (2019) Hydrocortisone granules are bioequivalent when sprinkled onto food or given directly on the tongue. Journal of the Endocrine Society, 3 (5). pp. 847-856. ISSN 2472-1972

Harrison, R.F., Debono, M., Whitaker, M.J. et al. (3 more authors) (2019) Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements. Journal of Clinical Endocrinology and Metabolism, 104 (3). pp. 765-772. ISSN 0021-972X

Daniel, E. orcid.org/0000-0003-4699-420X, Whitaker, M.J. orcid.org/0000-0003-2388-4753, Keevil, B. orcid.org/0000-0002-0684-9318 et al. (2 more authors) (2018) Accuracy of hydrocortisone dose administration via nasogastric tube. Clinical Endocrinology, 90 (1). pp. 66-73. ISSN 0300-0664

Elder, C.J., Harrison, R.F., Cross, A.S. et al. (4 more authors) (2018) Use of salivary cortisol and cortisone in the high and low dose synacthen test. Clinical Endocrinology , 88 (6). pp. 772-778. ISSN 2045-2322

Cross, A.S., Kemp, E.H. orcid.org/0000-0002-0313-8916, White, A. et al. (7 more authors) (2018) International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen. Clinical Endocrinology , 88 (5). pp. 744-751. ISSN 0300-0664

Jenkins-Jones, S., Parviainen, L., Porter, J. et al. (6 more authors) (2018) Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. European Journal of Endocrinology, 178 (4). pp. 309-320. ISSN 0804-4643

Melin, J., Parra-Guillen, Z.P., Hartung, N. et al. (4 more authors) (2018) Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults. Clinical Pharmacokinetics, 57. pp. 515-527. ISSN 0312-5963

Porter, J., Withe, M. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2018) Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme). Expert Review of Endocrinology & Metabolism, 13 (3). pp. 119-124. ISSN 1744-6651

Johannsson, G., Bidlingmaier, M., Biller, B.M.K. et al. (28 more authors) (2018) Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocrine Connections, 7 (3). R126-R134. ISSN 2049-3614

Neumann, U., Whitaker, M.J., Wiegand, S. et al. (7 more authors) (2018) Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clinical Endocrinology, 88 (1). pp. 21-29. ISSN 0300-0664

Johnson, T.N., Whitaker, M.J., Keevil, B. et al. (1 more author) (2017) Bioavailability of oral hydrocortisone corrected for binding proteins and measured by LC-MS/MS using serum cortisol and salivary cortisone. Journal of Bioequivalence and Bioavailability, 10 (1). pp. 1-3. ISSN 0975-0851

Neumann, U., Burau, D., Spielmann, S. et al. (4 more authors) (2017) Quality of compounded hydrocortisone capsules used in the treatment of children. European Journal of Endocrinology, 177 (2). ISSN 0804-4643

Porter, J., Blair, J. and Ross, R.J. orcid.org/0000-0001-9222-9678 (2017) Is physiological glucocorticoid replacement important in children? Archives of Disease in Childhood, 102. pp. 199-205. ISSN 0003-9888

Karunasena, N., Margetson, D., Neal, G. et al. (2 more authors) (2017) Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia. European Journal of Endocrinology. ISSN 0804-4643

Jones, C.M., Mallappa, A., Reisch, N. et al. (10 more authors) (2016) Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. jc20162855. ISSN 0021-972X

Wilkinson, I.R., Pradhananga, S.L., Speak, R. et al. (3 more authors) (2016) A long-acting GH receptor antagonist through fusion to GH binding protein. Scientific Reports, 6. p. 35072. ISSN 2045-2322

Christiansen, J.S., Backeljauw, P., Bidlingmaier, M. et al. (38 more authors) (2016) Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. European Journal of Endocrinology, 174. C1-C8. ISSN 0804-4643

Hummel, S.R., Sadler, S. orcid.org/0000-0001-5935-8507, Whitaker, M.J. et al. (3 more authors) (2016) A Model for Measuring the Health Burden of Classic Congenital Adrenal Hyperplasia in Adults. Clinical Endocrinology. ISSN 0300-0664

Allen, D.B., Backeljauw, P., Bidlingmaier, M. et al. (37 more authors) (2016) GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 174 (2). P1-P9. ISSN 0804-4643

Debono, M., Harrison, R.F., Whitaker, M.J. et al. (4 more authors) (2016) Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone. The Journal of Clinical Endocrinology & Metabolism, 101 (4). pp. 1469-1477. ISSN 0021-972X

Debono, M., Mallappa, A., Gounden, V. et al. (7 more authors) (2015) Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. European Journal of Endocrinology, 173 (6). pp. 727-737. ISSN 0804-4643

Bielohuby, M., Zarkesh-Esfahani, S.H., Manolopoulou, J. et al. (9 more authors) (2014) Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits. Disease Models and Mechanisms, 7 (11). pp. 1263-1273. ISSN 1754-8403

Whitaker, M.J., Debono, M., Huatan, H. et al. (3 more authors) (2014) An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clinical Endocrinology, 80 (4). pp. 554-561. ISSN 0300-0664

Debono, M., Chadarevian, R., Eastell, R. orcid.org/0000-0002-0323-3366 et al. (2 more authors) (2013) Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study. PLOS ONE, 8 (4). ARTN e60984. ISSN 1932-6203

Han, T.S., Krone, N. orcid.org/0000-0002-3402-4727, Willis, D.S. et al. (8 more authors) (2013) Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). EUROPEAN JOURNAL OF ENDOCRINOLOGY, 168 (6). pp. 887-893. ISSN 0804-4643

Guesdon, F., Kaabi, Y., Riley, A.H. et al. (6 more authors) (2012) Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling. Bioscience Reports, 32 (6). 653 - 660. ISSN 0144-8463

Debono, M., Ghobadi, C., Rostami-Hodjegan, A. et al. (7 more authors) (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94 (5). pp. 1548-1554. ISSN 0021-972X

Greenfield, D.M., Wright, J., Brown, J.E. et al. (6 more authors) (2006) High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening. British Journal of Cancer, 94. pp. 469-472. ISSN 0007-0920

Monograph

Dixon, S., Lewis, J., Debono, M. et al. (7 more authors) (2024) The cost-effectiveness of using waking salivary cortisol in the diagnosis of adrenal sufficiency. Report. SCHARR HEDS Discussion Papers (24.04). Sheffield Centre for Health and Related Research, University of Sheffield

Proceedings Paper

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Krone, N.P., Dawson, J.F. et al. (15 more authors) (2024) 6437 Analysis of 17-OH-progesterone (17OHP) and androstenedione (A4) profiles to rationalise biochemical monitoring of CAH patients. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 9341 CHAMPAIN Study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .